| abstract |
The invention relates to 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-diene-11-aryl derivatives of formula (I) having an antagonist effect on progesterone, and to a method for the production thereof, to the use thereof for treating and/or preventing illnesses, and to the use thereof for producing medications for treating and/or preventing illnesses, in particular uterine fibroids (myoma, uterine leiomyoma), endometriosis, severe menstrual bleeding, meningioma, hormone-related mamma carcinomas, and disorders associated with menopause, or for fertility control and emergency contraception. |